Cargando…
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
Ivermectin has become a controversial potential medicine for coronavirus disease 2019. Some early studies suggested clinical benefits in treatment of infection. However, the body of evidence includes studies of varying quality. Furthermore, some trials have now been identified as potentially fraudul...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774052/ https://www.ncbi.nlm.nih.gov/pubmed/35071686 http://dx.doi.org/10.1093/ofid/ofab645 |